CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 620 enrolled
Drug / intervention
BLI4700 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03404401
NCT03404401Phase 3Completed
CompareCT.gov

BLI4700-301: A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Braintree Laboratories·interventional·Posted Jan 19, 2018·Updated Sep 8, 2021

In Brief

A Phase 3 clinical trial evaluating BLI4700 and Polyethylene glycol bowel preparation for Colonoscopy. Completed, enrolled 620 participants across 23 sites.

Detailed Summary

The objective of this study is to compare the safety and efficacy of BLI4700 bowel preparation to an FDA-approved bowel preparation as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedJan 19, 2018
Enrollment StartJan 11, 2018
Primary CompletionJul 10, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 8.5 years ago

Interventions

BLI4700drug

Oral bowel preparation

Polyethylene glycol bowel preparationdrug

Oral bowel preparation